Jin Li

Chief Executive Officer at HITGEN INC.

Net worth: 546 M $ as of 30/09/2026

63 year

Health Technology

Consumer Services

Profile

Jin Li is the founder of HitGen, Inc. established in 2012, where he holds the title of Chairman & General Manager.
He is currently the Director at HitGen UK Ltd. since 2020.
Dr. Li was previously the Director at Phynova Group Ltd. from 2008 to 2009.
He received his doctorate degree from the University of Aston in 1988.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
HITGEN INC. CLASS A 20.46%	22/09/2026	81,970,948 ( 20.46% )	546 M $	30/09/2026

Jin Li active positions

Companies	Position	Start
HITGEN INC.	Chief Executive Officer	01/06/2012
HitGen UK Ltd. HitGen UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company	Director/Board Member	05/10/2020

All active positions of Jin Li

Former positions of Jin Li

Companies	Position	End
Phynova Group Ltd. Phynova Group Ltd. Pharmaceuticals: OtherHealth Technology Operates as a life science company that develops and commercializes natural health ingredients powered by plants	Director/Board Member	-

See the detail of Jin Li's experience

Education of Jin Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jin Li's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Phynova Group Ltd. Phynova Group Ltd. Pharmaceuticals: OtherHealth Technology Operates as a life science company that develops and commercializes natural health ingredients powered by plants	Health Technology
University of Aston University of Aston Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
HitGen, Inc. HitGen, Inc. BiotechnologyHealth Technology Develops innovative drugs	Health Technology
HitGen UK Ltd. HitGen UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company	Health Technology